On April 14, 2016, the Forum for Collaborative HIV Research convened the 15th HCV Drug Development Advisory Group(DrAG) Meeting in Barcelona, Spain in conjunction with the EASL’s 2016 International Liver Congress*.
At the 15th HCV DrAG Meeting, topics of discussion included:
Measuring Impact of RAVs- Anita Howe, British Columbia Center for Excellence in HIV/AIDS
Databases: Expanding Collaborations- Robert Shafer, Stanford University
At the 15th HCV DrAG Meeting, topics of discussion included:
- Focus on drug resistance standardization analysis
- Focus on drug resistance standardization reporting
- The proposal for collaboration to develop an HCV resistance database
Agenda
Participant List
Welcome and Updates - Veronica Miller, The Forum for Collaborative HIV Research
Presentations
Standardizing Resistance Reporting- Jackie Reeves, Monogram BiosciencesMeasuring Impact of RAVs- Anita Howe, British Columbia Center for Excellence in HIV/AIDS
Databases: Expanding Collaborations- Robert Shafer, Stanford University
*This is not an official function/event of the European Association for the Study of the Liver.
